Search - tctmd.com

Displaying 481 - 500 of 2594

Sort: Relevancy | Date

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

News Daily News

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Michael O'Riordan

April 11, 2023

News Daily News

Third-Trimester Preeclampsia Screening Still Worthwhile, Data Suggest

Caitlin E. Cox

April 11, 2023

News Daily News

Moderate-Intensity Exercise Possible For Patients With Statin Side Effects

Michael O'Riordan

April 03, 2023

News Opinion CV Team Dispatch

April 2023 News Roundup

L.A. McKeown

April 01, 2023

News Daily News

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Michael O'Riordan

March 31, 2023

News Daily News

Another Recall Warns of Unheralded Shutdowns With Cardiosave IABPs

Shelley Wood

March 31, 2023

News Daily News

Similarly Low Risk of CV Events With Bivalent and Monovalent mRNA Boosters

Shelley Wood

March 29, 2023

News Daily News

Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term

Caitlin E. Cox

March 28, 2023

News Daily News

MI Risk in Subclinical CAD? Both Extent and Stenosis Severity Matter

Yael L. Maxwell

March 27, 2023

News Daily News

Longer and Greater Risk Factor Exposure, More CVD

Caitlin E. Cox

March 23, 2023

News Daily News

Sugar Substitute Erythritol Linked to Cardiac Risk

Yael L. Maxwell

March 15, 2023

News Daily News

Mediterranean Diet’s CV Benefits Extend to Women: Meta-analysis

Caitlin E. Cox

March 15, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Conference News ACC 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Michael O'Riordan

March 13, 2023

News Conference News ACC 2023

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

L.A. McKeown

March 10, 2023

News Conference News ACC 2023

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

Todd Neale

March 10, 2023

News Conference News ACC 2023

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Michael O'Riordan

March 10, 2023

Advertisement

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Third-Trimester Preeclampsia Screening Still Worthwhile, Data Suggest

Moderate-Intensity Exercise Possible For Patients With Statin Side Effects

April 2023 News Roundup

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Another Recall Warns of Unheralded Shutdowns With Cardiosave IABPs

Similarly Low Risk of CV Events With Bivalent and Monovalent mRNA Boosters

Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term

MI Risk in Subclinical CAD? Both Extent and Stenosis Severity Matter

Longer and Greater Risk Factor Exposure, More CVD

Sugar Substitute Erythritol Linked to Cardiac Risk

Mediterranean Diet’s CV Benefits Extend to Women: Meta-analysis

March 2023 News Roundup

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content